ICB/FW/PSA6/MOH-GF-ARV/PH/01/20
July 10, 2020
Tender Code: ICB/FW/PSA6/MOH-GF-ARV/PH/01/20
Award Status: Amendment
Award Date: 07/06/2020
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
Company Name: | Document No: OF/TM/ HO-15 | |||||||||||
የኢትዮጵያ መድሃኒት አቅራቢ ኤጀንሲ | ||||||||||||
Ethiopian Pharmaceuticals Supply Agency | ||||||||||||
Title: | Effective date : 13/09/2019 | |||||||||||
Re-evaluation official Winner list | Rev. No.: 0 | Page 1 of 1 | ||||||||||
Tender no, ICB/FW/PSA6/MOH-GF-ARV/PH/01/20 | ||||||||||||
Ser NO | Description | Unit | Estimated Quantity | Winner | Currency | Unit FOB price | allocated quantity | Payment Term | port of shipment | Delivery Time | Remark | |
Supplier | Country | |||||||||||
2 | Lamivudine + Efavirenz + Tenofovir DF (TLE) – (300mg + 400mg + 300mg) – Tablet | 30 | 1,419,857 | Laurus labs | India | USD | 5.40 | 851,914 | CAD/LC | Hyderabad air or vishakapatnam sea | Within 90 days after LC opening date or CAD reservation date | Winner price |
Mylan Lab | India | USD | 5.41 | 354,964 | CAD | Mumbai | Within 90 days afterCAD reservation date | 2nd least price | ||||
Macleod | India | USD | 5.51 | 212,979 | LC | Mumbai,Delhi | Within 90 days after LC opening | 3rd least price |
Reasons for Rejection
Company Name: | Document No: OF/TM/ HO-17 | ||||
የኢትዮጵያመድሃኒትአቅራቢኤጀንሲ | |||||
Ethiopian Pharmaceuticals Supply Agency | |||||
Title: | Effective date : 13/09/2019 | ||||
Reasons for Rejection | Rev. No.: 0 | Page 1 of 1 | |||
Tender no,:ICB/FW/PSA6/MOH-GF-ARV/PH/01/20 | |||||
item No | Prdoduct Description | Name of competitor suppliers | Status | reason of unsuccessfulness(if it is unsuccessful) | Remark |
2 | Lamivudine + Efavirenz + Tenofovir DF (TLE) – (300mg + 400mg + 300mg) – Tablet | Laurus labs | Winner | ||
Macleod | ………………… | price incomptence | |||
Mylan | ……………….. | price incomptence |